Drug candidate significantly reduces HIV reactivation rate

Unlike other antiretroviral therapies, a natural compound called Cortistatin A reduces residual levels of HIV virus from infected dormant cells, establishing a near-permanent state of latency and greatly diminishing the virus' capacity for reactivation, scientists report.